Ntilara Touzlatzi
Overview
Explore the profile of Ntilara Touzlatzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papadopoulos V, Koutroulos M, Zikoudi D, Bakola S, Avramidou P, Touzlatzi N, et al.
Diabetol Int
. 2021 Mar;
12(4):445-459.
PMID: 33777611
Aims: COVID-19 is associated with diabetic ketoacidosis (DKA), hyperglycaemic hyperosmolar state (HHS) and euglycaemic DKA (EDKA); however, evidence regarding parameters affecting outcome and mortality rates is scarce. Methods: A systematic...
2.
Orfanidou M, Lafioniatis A, Trevlopoulou A, Touzlatzi N, Pitsikas N
Nitric Oxide
. 2017 May;
69:56-60.
PMID: 28522342
The nitric oxide (NO) donor sodium nitroprusside (SNP) actually is under investigation for the treatment of schizophrenia. That anxiety disorders are noted to occur commonly in schizophrenia patients is known....
3.
Trevlopoulou A, Touzlatzi N, Pitsikas N
Psychopharmacology (Berl)
. 2015 Dec;
233(6):1045-54.
PMID: 26685991
Rationale: Experimental evidence indicates that the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist ketamine impairs cognition and can mimic certain aspects of positive and negative symptoms of schizophrenia in rodents. Nitric oxide...